We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.7B
AUM Growth
+$2.5B
Cap. Flow
+$2B
Cap. Flow %
18.71%
Top 10 Hldgs %
43.17%
Holding
3,695
New
1,259
Increased
473
Reduced
526
Closed
1,295

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$136M
2
LIN icon
Linde
LIN
+$111M
3
VLO icon
Valero Energy
VLO
+$106M
4
PANW icon
Palo Alto Networks
PANW
+$105M
5
LMT icon
Lockheed Martin
LMT
+$104M

Sector Composition

Rank Sector Weight
1 Technology 8.52%
2 Consumer Discretionary 7.25%
3 Industrials 6.98%
4 Financials 6.35%
5 Healthcare 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
2001
Celularity
CELU
$19.8M
$74K ﹤0.01%
+14,009
New +$89.7K
DHY
2002
Credit Suisse High Yield Credit Fund
DHY
$238M
$74K ﹤0.01%
+39,441
New +$74.8K
SYRE icon
2003
Spyre Therapeutics
SYRE
$9.12B
$74K ﹤0.01%
+6,581
New +$31.2K
ASST icon
2004
Strive Inc
ASST
$1.04B
$73K ﹤0.01%
+425
New +$52.6K
HIO
2005
Western Asset High Income Opportunity Fund
HIO
$337M
$72K ﹤0.01%
19,181
-1,266
-6% -$4.8K
LEO
2006
BNY Mellon Strategic Municipals
LEO
$384M
$72K ﹤0.01%
+11,663
New +$71.8K
VRN
2007
DELISTED
Veren
VRN
$70K ﹤0.01%
10,495
-19,643
-65% -$137K
CNSL
2008
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$68K ﹤0.01%
17,982
-34,954
-66% -$126K
SLGC
2009
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$64K ﹤0.01%
+28,035
New +$79.2K
NAMSW icon
2010
NewAmsterdam Pharma Warrant
NAMSW
$73.6M
$63K ﹤0.01%
30,321
ME
2011
DELISTED
23andMe Holding Co
ME
$63K ﹤0.01%
1,816
-1,646
-48% -$65.5K
MF
2012
DELISTED
Missfresh Limited American Depositary Shares
MF
$63K ﹤0.01%
121,991
-120,039
-50% -$91.9K
GGN
2013
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$801M
$62K ﹤0.01%
16,816
-6,953
-29% -$26K
ORGN
2014
DELISTED
Origin Materials
ORGN
$61K ﹤0.01%
+479
New +$61.7K
GRPN icon
2015
Groupon
GRPN
$955M
$59K ﹤0.01%
+10,003
New +$44.3K
INSG icon
2016
Inseego
INSG
$87.1M
$58K ﹤0.01%
+9,034
New +$72.2K
CONN
2017
DELISTED
Conn's Inc.
CONN
$58K ﹤0.01%
+15,872
New +$71.9K
JSPR icon
2018
Jasper Therapeutics
JSPR
$21.5M
$56K ﹤0.01%
+4,126
New +$61.3K
ORGO icon
2019
Organogenesis Holdings
ORGO
$310M
$56K ﹤0.01%
17,126
-340,670
-95% -$1.01M
RAD
2020
DELISTED
Rite Aid Corporation
RAD
$56K ﹤0.01%
+37,312
New +$74.7K
DBGI
2021
Digital Brands Group
DBGI
$8.41M
$56K ﹤0.01%
+2
New +$90.4K
PLBY icon
2022
Playboy Inc
PLBY
$134M
$55K ﹤0.01%
+32,897
New +$55.6K
CMCT
2023
Creative Media & Community Trust
CMCT
$12.8M
0
AMBI.WS
2024
DELISTED
Ambipar Emergency Response Warrants
AMBI.WS
$53K ﹤0.01%
106,117
GGRP
2025
Glimpse Group
GGRP
$18.9M
$53K ﹤0.01%
+15,004
New +$61.5K

Similar funds

HRT Financial's Q2 2023 Portfolio in Review

As of Q2 2023, HRT Financial held 3,695 positions worth $10.7B, up 30% from $8.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

HRT Financial deployed $2B of net new capital in Q2 2023, opening 1,259 new positions and adding to 473 existing holdings. Its largest new stake was Blackstone: 1,401,378 shares worth $130M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $136M trimmed.

  • HRT Financial's largest Q2 2023 buy was Blackstone: 1,401,378 shares worth $130M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $2.08B increase.
  • HRT Financial's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $136M.
  • HRT Financial fully exited Palo Alto Networks in Q2 2023, selling an estimated $105M.
  • HRT Financial's ten largest holdings make up 43% of its $10.7B portfolio in Q2 2023.
  • HRT Financial opened 1,259 new positions and closed 1,295 in Q2 2023.
  • HRT Financial's portfolio value rose 30% quarter-over-quarter to $10.7B.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.